EPFB
RMD icon

Employees Provident Fund Board’s ResMed RMD Stock Holding History

Employees Provident Fund Board’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$91.2M Buy
468,004
+38,105
+9% +$7.9M 0.52% 39
2026
Q1 		$96.5M Buy
429,899
+71,798
+20% +$17.9M 0.73% 39
2025
Q4 		$86.3M Buy
358,101
+62,402
+21% +$16M 0.63% 41
2025
Q3 		$80.9M Sell
295,699
-114,143
-28% -$31.2M 0.65% 40
2025
Q2 		$106M Buy
409,842
+39,014
+11% +$9.31M 0.91% 36
2025
Q1 		$83M Buy
370,828
+199,200
+116% +$46.5M 0.94% 43
2024
Q4 		$39.2M Sell
171,628
-25,721
-13% -$6.19M 0.49% 50
2024
Q3 		$48.2M Sell
197,349
-135,223
-41% -$30.2M 0.66% 50
2024
Q2 		$63.7M Buy
332,572
+147,427
+80% +$29.9M 1.02% 40
2024
Q1 		$36.7M Sell
185,145
-403,017
-69% -$73.8M 0.64% 48
2023
Q4 		$101M Buy
588,162
+332,540
+130% +$51.1M 1.98% 18
2023
Q3 		$37.8M Buy
255,622
+152,753
+148% +$27.6M 0.86% 44
2023
Q2 		$22.5M Buy
102,869
+91,869
+835% +$20.5M 0.53% 49
2023
Q1 		$2.41M Hold
11,000
– – 0.06% 83
2022
Q4 		$2.29M Sell
11,000
-600
-5% -$132K 0.07% 69
2022
Q3 		$2.53M Sell
11,600
-65,481
-85% -$14.9M 0.07% 65
2022
Q2 		$16.2M Buy
77,081
+49,964
+184% +$10.6M 0.37% 58
2022
Q1 		$6.58M Buy
+27,117
New +$6.56M 0.11% 70

Other funds holding RMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Employees Provident Fund Board's RMD Position: Q2 2026 in Review

Employees Provident Fund Board increased its ResMed (RMD) stake by 8.9% in Q2 2026, buying an estimated $7.9M and bringing the position to 468,004 shares worth $91.2M. The position accounts for 0.52% of the portfolio, ranked #39.

Employees Provident Fund Board first reported a position in RMD in Q1 2022 and has held it in 18 quarters since. The position peaked at $106M in Q2 2025. 879 funds tracked by Wall St. Rank hold RMD as of Q2 2026.

  • Employees Provident Fund Board held 468,004 shares of ResMed worth $91.2M as of Q2 2026.
  • Employees Provident Fund Board bought 38,105 ResMed shares in Q2 2026, an estimated $7.9M.
  • ResMed made up 0.52% of Employees Provident Fund Board's portfolio in Q2 2026, its #39 holding.
  • Employees Provident Fund Board first reported a position in ResMed in Q1 2022 and has held it in 18 quarters since.
  • Employees Provident Fund Board's ResMed position peaked at $106M in Q2 2025.
  • 879 funds tracked by Wall St. Rank held ResMed as of Q2 2026.

Based on Employees Provident Fund Board's 13F filing for Q2 2026, filed 12 Aug 2026.